Benign neoplasm: Bone and articular cartilage, unspecified

CD2_BENIGN_BONE_CARTILAGE_NOS

bone neoplasm: A benign, intermediate, or malignant neoplasm involving the bone or articular cartilage.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D16.90&, D16.91& Hospital discharge: ICD-9 — 2139 Hospital discharge: ICD-8 — 2130[8-9] Cause of death: ICD-10 — D16.90&, D16.91& Cause of death: ICD-9 — 2139 Cause of death: ICD-8 — 2130[8-9] 2 out of 7 registries used, show all original rules.	275
4. Check minimum number of events None	275
5. Include endpoints None	275
6. Filter based on genotype QC (FinnGen only)	275

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	CD2_BENIGN_BONE_CARTILAGE_NOS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D169
HD_ICD_9	2139
HD_ICD_8	2130[8-9]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D169
COD_ICD_9	2139
COD_ICD_8	2130[8-9]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Bone and articular cartilage, unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Bone and articular cartilage, unspecified

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	2211	1137	1059
Only index persons	1934	1023	911
Unadjusted period prevalence (%)
Whole population	0.03	0.03	0.03
Only index persons	0.04	0.04	0.03
Median age at first event (years)
Whole population	35.83	38.19	33.13
Only index persons	33.83	37.05	30.22

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	275	158	117
Unadjusted period prevalence (%)	0.05	0.05	0.05
Median age at first event (years)	38.62	38.37	38.96

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
245: Matched controls
2447

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D16.90

ICD-10 Finland

Bone and articular cartilage, unspecified

+∞

169.0

142

21309

ICD-8 Finland

Benign neoplasm of bone and cartilage, Unspecified

+∞

45.2

21308

ICD-8 Finland

Benign neoplasm of bone and cartilage, Loco alio sive multiplici

+∞

34.2

2139X

ICD-9 Finland

Benign neoplasm of bone and articular cartilage, Bone and articular cartilage, site unspecified

+∞

20.1

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

18.0

13.2

AAP10

NOMESCO Finland

Extirpation of a skull lesion

+∞

12.6

D16.49

ICD-10 Finland

Bones of skull and face

+∞

10.5

D16.2

ICD-10 Finland

Benign neoplasm: Long bones of lower limb

57.3

9.7

9102

FHL

Trepanation or removal of the local bone process

18.4

9.5

D16.9

ICD-10 Finland

Benign neoplasm: Bone and articular cartilage, unspecified

+∞

8.4

NDR20

NOMESCO Finland

Incomplete excision of soft tissue tumour of wrist or hand

12.3

8.2

D16.1

ICD-10 Finland

Benign neoplasm: Short bones of upper limb

46.5

7.8

D16.91

ICD-10 Finland

Benign tumor in unspecified localization in bone with urpsrung in teeth

+∞

7.3

D16.0

ICD-10 Finland

Benign neoplasm: Scapula and long bones of upper limb

31.0

7.2

NFR20

NOMESCO Finland

Incomplete excision of soft tissue tumour of hip or thigh

71.6

6.5

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

382

1.92

4.68

1.4

1.3

5.4

8.1

u/ml

0.23

152

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

402

1.88

4.52

1.5

1.3

55.7

24.6

iu/ml

0.32

130

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

129

986

1.58

3.43

4.7

7.1

1.2

mmol/l

0.12

112

828

(3026493) Urate [Moles/volume] in Serum or Plasma

558

1.61

3.07

2.2

2.5

320.1

4367.3

umol/l

1.81

488

(3013826) Glucose [Moles/volume] in Serum or Plasma

153

1236

1.54

3.06

3.6

5.0

6.4

6.6

mmol/l

0.59

137

1145

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

116

897

1.51

2.77

4.0

6.1

1.2

mmol/l

0.06

100

820

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

246

1.73

2.45

5.8

6.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

132

1.98

2.45

1.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

193

1694

1.47

2.21

7.7

7.1

74.7

78.1

u/l

0.68

185

1583

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

4.36

2.16

1.8

1.5

0.8

1.0

g/l

—

(3037522) Nuclear Ab [Titer] in Serum

325

1.58

2.05

1.5

1.3

724.0

525.6

titre

—

(3013707) Erythrocyte sedimentation rate by Westergren method

189

1663

1.44

2.05

4.4

3.8

9.6

10.5

mm/h

0.42

176

1529

(3007853) Bacteria identified in Skin by Aerobe culture

253

1.63

1.98

1.5

1.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

244

2273

1.65

1.89

13.8

14.6

3.9

4.0

mmol/l

0.52

238

2207

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

2.70

1.88

1.9

1.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

643

1.42

1.84

1.7

2.0

296.9

230.8

u/l

0.29

605

(3019550) Sodium [Moles/volume] in Serum or Plasma

243

2268

1.61

1.78

13.8

14.6

139.6

139.7

mmol/l

0.25

236

2205

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

242

2257

1.60

1.77

13.5

13.0

20.0

21.5

mg/l

0.35

201

1739

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

191

1708

1.39

1.71

4.0

3.9

14.4

14.6

pmol/l

0.61

174

1559

(40768804) Tissue Pathology biopsy report

109

894

1.36

1.70

2.1

1.9

—

(3042936) Bacteria identified in Isolate by Culture

297

1.53

1.69

2.0

2.2

—

(3008898) HLA-B27 [Presence]

106

1.85

1.63

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

595

1.38

1.56

3.3

4.1

3.6

9.0

mg/mmol

1.77

387

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

2.63

1.52

1.3

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

222

2053

1.42

1.50

4.8

4.6

1.7

2.4

mu/l

0.73

207

1899

(40768443) Skin Pathology biopsy report

1.87

1.45

1.5

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

3.16

1.44

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

128

1.69

1.38

2.1

1.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

813

1.32

1.37

2.8

3.6

81.1

39.9

ng/l

0.32

513

(4281824)

2.98

1.36

1.0

1.1

—

(3044889) 12 lead EKG panel

171

1536

1.30

1.29

3.4

3.5

—

(40768797) Stomach Pathology biopsy report

289

1.45

1.29

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

2.81

1.29

1.0

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

683

1.31

1.21

2.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

2.34

1.19

2.7

2.1

14.0

13.1

—

(3012516) Albumin [Mass/volume] in Urine

565

1.32

1.17

2.8

3.3

1002.9

162.4

mg/l

0.40

373

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1.85

1.17

1.0

1.1

—

3.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

1.17

0.0

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

706

1.30

1.16

3.2

3.3

2.4

2.3

mmol/l

0.29

634

(3021788) Differential panel - Synovial fluid

2.37

1.13

1.9

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

2.03

1.13

1.0

1.5

—

(3019225) pH of Specimen

186

1.50

1.11

2.0

4.6

—

(3032080) INR in Blood by Coagulation assay

814

1.28

1.11

5.7

8.2

1.2

inr

0.07

256

(3024561) Albumin [Mass/volume] in Serum or Plasma

102

874

1.27

1.08

4.4

4.7

36.7

36.1

g/l

0.49

827

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

499

1.31

1.06

1.4

1.7

0.7

1.1

mg/l

1.96

388

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.67

1.06

2.8

2.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.77

1.04

2.3

1.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.77

1.04

2.3

1.7

7.8

7.5

g/l

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.77

1.04

2.3

1.7

4.8

3.8

g/l

—

(3007566) Smooth muscle Ab [Titer] in Serum

1.87

1.04

1.0

1.1

—

80.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

2.09

1.03

2.4

2.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

156

1.52

1.02

1.7

2.6

74.0

69.1

ml/min/173m2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

502

1.30

1.01

2.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

339

1.35

1.01

2.4

2.5

3.8

1.0

e6/l

0.51

185

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.88

0.98

1.8

2.3

—

(3052851) Hemolysis interference index of Serum or Plasma

1.88

0.98

3.1

2.5

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1.88

0.98

1.3

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

0.98

0.0

1.3

—

9.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1.97

0.97

1.1

1.9

2.5

2.8

u/ml

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

533

1.29

0.97

2.0

3.2

495.3

1155.4

ng/l

2.63

445

(3012544) pH of Venous blood

175

1.47

0.97

1.9

3.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.97

0.0

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.95

0.0

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.95

0.0

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.95

0.0

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.95

0.0

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

245

1.39

0.94

1.9

5.5

1.1

1.0

mmol/l

0.55

226

(40768800) Prostate Pathology biopsy report

1.91

0.94

1.1

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

165

1509

1.23

0.93

4.4

3.9

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.85

0.93

1.6

1.5

—

(40758558) Short blood count panel - Blood

537

1.28

0.92

7.2

6.5

—

(3002032) Base excess in Venous blood by calculation

169

1.46

0.91

1.9

3.0

1.7

2.2

mmol/l

0.22

132

(21494755) Public health laboratory ask at order entry panel

284

0.68

0.88

1.2

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.75

0.87

1.1

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

2.02

0.87

1.3

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

101

883

1.23

0.87

2.2

74.1

74.0

nmol/l

0.02

794

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

513

1.27

0.86

1.4

1.3

5.1

1.3

u/ml

0.45

136

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

749

1.24

0.86

2.9

3.0

—

(3000850) Epithelial cells [#/volume] in Urine

449

1.28

0.85

2.0

2.5

5.1

5.3

e6/l

0.05

402

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1.96

0.85

1.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.72

0.83

1.1

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.72

0.83

1.1

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

126

1131

1.21

0.82

6.3

6.2

12.8

10.8

umol/l

0.44

121

1073

(3018418) pH of Serum or Plasma

610

1.24

0.82

3.3

3.5

7.4

—

114

(3024139) IgG subclass 3 [Mass/volume] in Serum

0.00

0.79

0.0

1.2

—

0.3

—

(4062490)

0.00

0.79

0.0

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

0.00

0.79

0.0

1.2

—

6.6

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

0.00

0.79

0.0

1.2

—

2.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

317

1.31

0.78

2.5

2.7

4.4

2.6

e6/l

0.65

163

(3025941) Bacteria identified in Stool by Culture

124

1.48

0.77

1.2

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

0.00

0.76

0.0

3.5

—

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.76

0.0

1.3

—

(3013115) Eosinophils [#/volume] in Blood

126

1138

1.20

0.76

6.1

5.7

0.2

e9/l

0.19

112

1004

(3045142) Bone marrow Pathology biopsy report

2.10

0.75

1.0

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

117

1.48

0.73

1.1

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1.82

0.73

1.4

1.3

398.0

12.7

u/l

—

(3017181) Myelocytes/100 leukocytes in Blood

169

1.39

0.72

3.6

4.3

0.5

0.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

143

0.62

0.72

1.3

1.5

—

(3018010) Neutrophils/100 leukocytes in Blood

118

1064

1.19

0.71

6.3

5.2

56.7

57.2

0.19

110

998

(3014576) Chloride [Moles/volume] in Serum or Plasma

231

1.34

0.71

4.1

7.4

104.0

103.9

mmol/l

0.03

224

(3023419) Bacteria identified in Sputum by Culture

1.94

0.71

1.2

2.5

—

(3030467) Casts [#/volume] in Urine by Automated count

586

1.21

0.66

2.7

2.9

0.1

0.5

e6/l

1.76

436

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

226

1.32

0.65

3.1

3.8

370.6

234.3

u/l

0.70

212

(40761511) CBC panel - Blood by Automated count

246

2384

1.30

0.64

12.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

164

0.66

0.63

6.9

7.9

1.1

1.3

mmol/l

1.02

158

(3049717) Cytology report of Urine Cyto stain

1.61

0.62

1.9

2.6

—

(3019198) Lymphocytes [#/volume] in Blood

124

1134

1.17

0.62

6.3

5.4

2.0

2.1

e9/l

0.15

112

1006

(3026008) Bacteria identified in Urine by Culture

581

1.20

0.62

2.6

2.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

393

1.24

0.61

1.3

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

384

1.24

0.61

2.7

2.8

2.4

2.5

mmol/l

0.06

337

(3013650) Neutrophils [#/volume] in Blood by Automated count

139

1284

1.17

0.61

9.5

9.1

4.0

4.1

e9/l

0.18

121

1117

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.52

0.61

1.2

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.60

0.0

2.3

—

(3008295) Osmolality of Serum or Plasma

0.00

0.60

0.0

1.7

—

276.3

—

(42870588) Differential panel, method unspecified - Blood

726

1.18

0.60

5.6

5.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

357

1.24

0.60

1.4

1.7

1106.8

1219.0

nmol/l

0.42

272

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.59

0.0

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.59

0.0

1.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

0.00

0.59

0.0

2.4

—

60.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.59

0.0

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.59

0.0

1.6

—

(3009508) Creatinine [Moles/volume] in Urine

631

1.19

0.59

2.8

3.1

8.1

7.8

mmol/l

0.19

547

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.58

0.0

4.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.68

0.57

1.2

1.0

—

(3048689) Calprotectin [Mass/mass] in Stool

277

1.26

0.56

2.1

65.8

112.6

ug/g

1.15

227

(3025159) Blasts/100 leukocytes in Blood

151

1.35

0.55

4.0

4.4

0.0

—

(4010399)

169

1.33

0.55

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

224

2159

1.20

0.54

4.0

4.3

5.7

5.9

mmol/l

1.19

206

1995

(3006504) Eosinophils/100 leukocytes in Blood

114

1045

1.16

0.54

6.3

5.3

2.9

2.8

0.20

106

969

(4035726)

179

1.31

0.53

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.55

0.53

1.0

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

219

2108

1.19

0.53

11.5

11.7

84.2

84.6

ml/min/173m2

0.10

176

1705

(36304419) Bacteria [Presence] in Urine

581

1.18

0.52

2.7

2.8

—

(3002030) Lymphocytes/100 leukocytes in Blood

117

1078

1.15

0.51

6.5

5.4

28.6

28.2

0.14

110

1007

(3019069) Monocytes/100 leukocytes in Blood

114

1049

1.15

0.51

6.8

5.6

8.5

8.4

0.10

105

986

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

136

1.35

0.50

1.4

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1.51

0.50

2.1

1.9

86.0

91.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

221

0.75

0.48

3.3

3.2

—

(3037121) Protein [Mass/volume] in Urine

1.49

0.47

2.3

3.1

0.2

g/l

—

(40760892) CBC W Ordered Manual Differential panel - Blood

519

1.17

0.47

4.8

4.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

163

1542

1.14

0.47

3.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

819

1.15

0.46

2.0

1.9

98.4

96.0

pmol/l

0.15

423

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

540

0.84

0.46

4.4

4.0

17.7

21.8

1.49

241

(3029937) Albumin [Presence] in Urine by Test strip

598

1.16

0.45

3.4

3.7

0.0

estimate

0.80

218

(3027945) Reticulocytes/100 erythrocytes in Blood

229

0.77

0.44

1.9

2.8

1.4

1.8

2.67

210

(3006315) Basophils [#/volume] in Blood

119

1109

1.13

0.42

6.3

5.4

0.0

e9/l

0.61

104

962

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

168

1599

1.13

0.42

3.6

3.1

48.1

46.6

u/l

0.08

161

1510

(3022096) Basophils/100 leukocytes in Blood

109

1011

1.13

0.42

6.2

5.4

0.7

0.13

102

940

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

105

1.35

0.42

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

0.41

0.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.41

0.0

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

0.41

0.0

2.3

—

613.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

242

1.22

0.41

4.1

4.4

35.1

31.0

1.28

155

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.41

0.0

1.2

—

(3018095) Leukocytes [#/volume] in Urine

758

1.14

0.41

3.2

3.5

138.9

68.5

e6/l

0.27

534

(3039443) Prostate specific Ag panel - Serum or Plasma

1.34

0.40

1.9

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.48

0.40

2.6

8.9

—

135.3

—

(3045424) Erythrocytes [Presence] in Urine

1.48

0.40

1.0

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

258

0.80

0.40

1.4

1.8

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

0.00

0.40

0.0

1.9

—

3.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.40

0.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.40

0.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1.44

0.39

1.0

—

6.2

—

(3001604) Monocytes [#/volume] in Blood

118

1104

1.12

0.39

6.3

5.3

0.6

e9/l

0.04

102

954

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

319

1.18

0.38

1.3

2.0

—

(3023520) Reticulocytes [#/volume] in Blood

169

0.76

0.38

2.2

2.8

49.9

70.2

e9/l

—

133

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

115

0.69

0.38

2.0

1.4

—

(3025130) Human papilloma virus identified in Specimen

1.36

0.37

2.0

1.9

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.36

0.37

3.0

1.6

—

(3003694) ABO and Rh group [Type] in Blood

643

0.88

0.36

1.4

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.47

0.36

1.2

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.47

0.36

1.2

1.4

—

(3026361) Erythrocytes [#/volume] in Blood

257

2528

1.25

0.36

20.4

18.8

4.6

4.5

e12/l

0.58

252

2471

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.44

0.36

1.2

1.1

—

(3037756) Immunofixation for Serum or Plasma

1.44

0.36

1.0

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

683

0.88

0.35

5.1

4.3

1.7

2.1

ug/l

0.58

610

(3004716) Salmonella sp identified in Stool by Organism specific culture

118

1.29

0.34

1.1

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

466

1.14

0.34

1.3

1.4

2.3

2.5

g/l

0.41

276

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

314

1.17

0.33

1.6

1.8

1.4

0.22

276

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.31

0.33

2.0

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

143

0.76

0.33

1.5

1.6

—

(3019150) Specific gravity of Urine by Refractometry

477

1.14

0.33

3.9

3.7

1.0

kg/l

—

(3022313) Gas panel - Capillary blood

1.32

0.32

2.7

2.9

—

(40761536) Microorganisms panel - Urine sediment

197

0.80

0.32

1.7

3.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

156

1.23

0.32

4.0

4.4

0.0

0.2

—

(3013512) EKG study

577

1.12

0.30

3.5

3.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.26

0.29

1.1

1.7

—

(36660697) Celiac disease serology panel - Serum

195

1.20

0.29

1.3

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.28

0.28

1.7

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

168

1.21

0.28

2.3

1.9

—

(3000492) Spirometry study

225

0.83

0.27

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

225

1.17

0.27

1.3

1.9

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.22

0.27

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

562

1.11

0.26

1.8

1.7

1.3

1.4

mmol/l

0.54

478

(3000494) Fungus identified in Specimen by Culture

254

1.16

0.26

1.1

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

0.69

0.26

1.8

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

866

1.09

0.26

3.3

3.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

0.66

0.26

1.6

1.9

4.9

ug/l

—

(3002582) Erythrocytes [#/volume] in Urine

651

1.10

0.25

2.7

3.0

42.0

55.6

e6/l

0.18

499

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.21

0.25

1.1

2.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

284

1.14

0.25

1.4

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

133

1.22

0.25

2.1

1.8

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1.28

0.24

1.2

1.3

—

1.9

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

244

2402

1.14

0.24

11.1

9.5

26.9

25.5

u/l

0.79

235

2326

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

106

1.24

0.23

4.7

14.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.75

0.23

1.3

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

1.22

0.22

3.0

3.4

12.6

39.1

u/ml

—

(3035350) Ketones [Presence] in Urine by Test strip

113

1081

1.08

0.22

3.3

3.4

0.0

estimate

0.00

219

(3027944) Amphetamines [Presence] in Urine

101

0.79

0.21

1.8

1.3

—

(3012565) Volume of 24 hour Urine

0.00

0.21

0.0

2.8

—

2209.1

—

(3034426) Prothrombin time (PT)

0.00

0.21

0.0

1.5

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

3.7

—

92.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.21

0.0

1.9

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

0.21

0.0

1.5

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.5

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.2

—

(3017569) Oxygen content in Arterial blood

0.00

0.21

0.0

8.5

—

(3017704) Immunofixation for Urine

0.00

0.21

0.0

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.5

—

(3010503) CD19 cells [#/volume] in Blood

0.00

0.21

0.0

1.5

—

0.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

394

1.11

0.21

2.6

3.8

437.5

251.7

ng/l

0.23

303

(40760888) Immunoglobulin light chains.free panel - Serum

1.17

0.21

2.2

3.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

280.9

—

(3000012) Reticulocyte production index

0.00

0.21

0.0

2.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.1

—

41.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

0.21

0.0

1.9

—

(3004451) EKG impression Narrative

0.00

0.21

0.0

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

520.4

—

(3004775) Volume in Urine collected for unspecified duration

0.00

0.21

0.0

3.1

—

680.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.26

0.21

2.6

1.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

0.20

0.0

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.20

0.0

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.20

0.0

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.20

0.0

1.2

—

7.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

1.23

0.20

4.2

4.6

—

(40761535) Cells panel - Urine sediment

165

1.16

0.19

3.2

3.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.18

0.19

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

203

2070

0.93

0.19

5.1

5.3

38.7

39.6

mmol/mol

0.69

192

1943

(3023511) Choriogonadotropin [Units/volume] in Urine

1.21

0.18

1.4

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.18

0.16

1.0

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.15

0.16

1.1

1.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

449

1.08

0.16

1.3

1.6

—

(4034850)

1.10

0.16

2.1

10.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

226

1.12

0.16

1.3

2.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

108

1042

1.06

0.15

4.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

501

0.93

0.15

1.5

18.5

21.1

nmol/l

0.74

425

(1002224) Polysomnography panel

121

1.17

0.15

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.10

0.15

1.7

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

257

1.10

0.14

1.3

1.4

—

(3023368) Bacteria identified in Blood by Culture

543

1.06

0.12

4.0

4.5

—

(3009261) Glucose [Presence] in Urine by Test strip

113

1099

1.05

0.12

3.3

3.4

0.0

estimate

0.00

212

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

229

2265

1.07

0.11

4.7

4.6

2.7

2.8

mmol/l

0.25

212

2101

(3009542) Hematocrit [Volume Fraction] of Blood

214

2113

1.06

0.11

15.6

13.6

39.8

40.6

0.76

169

1620

(3041096) Erythrocytes [Presence] in Urine by Automated

644

1.05

0.11

2.3

3.0

—

(3002256) Pathology report gross observation

271

1.08

0.10

1.6

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

479

1.05

0.09

4.2

3.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.80

0.08

1.4

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

244

1.07

0.08

1.6

—

(3020891) Body temperature

1.08

0.08

3.6

4.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

111

1087

1.04

0.08

4.5

4.6

0.0

estimate

0.50

218

(3011288) Drugs identified in Urine by Screen method

1.07

0.07

2.5

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.05

0.07

1.5

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

387

0.95

0.07

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.85

0.07

4.1

2.0

—

(3021589) Normoblasts [#/volume] in Blood

101

989

1.03

0.07

8.4

8.8

0.0

e9/l

1.38

800

(3050129) First trimester maternal screen panel - Serum or Plasma

0.88

0.07

1.8

1.4

—

(3022145) Colonoscopy Study observation

234

0.93

0.07

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

214

2158

0.96

0.06

3.6

3.8

1.2

1.3

mmol/l

2.24

196

1998

(3028300) Cannabinoids [Presence] in Urine

101

0.89

0.06

1.7

1.4

—

(3027008) Opiates [Presence] in Urine

101

0.89

0.06

1.7

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

100

0.90

0.06

1.7

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

264

0.94

0.06

1.6

1.7

—

(3000330) Specific gravity of Urine by Test strip

1.12

0.05

3.6

3.1

—

(1761868) Lipid panel - Serum or Plasma

896

0.97

0.05

2.3

2.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

170

0.94

0.04

1.2

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

225

2238

1.03

0.03

4.2

4.7

mmol/l

0.20

203

2092

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

290

1.04

0.03

1.8

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

320

1.04

0.03

2.0

2.1

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

118

0.93

0.03

7.4

9.8

1.8

1.5

0.41

118

(3019060) Gas panel - Arterial blood

132

1.06

0.02

3.4

7.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

471

1.02

0.02

1.8

1.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

222

2229

0.98

0.02

4.0

4.1

1.5

mmol/l

0.64

203

2073

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

117

0.94

0.02

7.4

10.0

0.7

0.08

117

(3000991) Gas panel - Venous blood

147

0.95

0.01

5.9

9.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

167

0.96

0.01

1.4

—

(3003396) Base excess in Arterial blood by calculation

216

0.97

0.00

5.6

10.7

1.6

1.5

mmol/l

0.04

174

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

396

0.98

0.00

3.1

2.8

1.3

0.7

ug/l

0.37

235

(3009343) pH of Capillary blood

128

1.02

0.00

2.5

3.1

—

7.4

—

(3022621) pH of Urine by Test strip

133

0.98

0.00

2.5

2.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

105

0.95

0.00

1.1

1.8

—

(3002385) Erythrocyte distribution width [Ratio]

192

1917

1.01

0.00

17.3

15.9

13.8

13.6

0.35

185

1887

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

0.0

2.2

—

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.0

1.7

—

(3002619) Bacteria identified in Specimen by Culture

0.00

0.0

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

17.8

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

0.0

6.8

—

39.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

0.91

0.00

1.6

1.3

—

44.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.91

0.00

1.2

—

(40768446) Kidney Pathology biopsy report

0.00

0.0

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.0

2.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.00

0.0

1.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

0.98

0.00

3.3

3.0

52.3

488.5

u/ml

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

0.00

0.0

1.0

—

6.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.0

1.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.0

5.6

—

(40765096) Chromosome analysis panel by Banding

0.00

0.0

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

0.0

8.0

—

(37021550) Renin [Units/volume] in Plasma --upright

0.00

0.0

1.6

—

156.7

—

(3024471) HLA-A [Type]

0.00

0.0

1.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

0.84

0.00

1.2

1.1

—

(3024932) HLA-DR beta [Type]

0.00

0.0

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.0

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

0.0

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.0

1.6

—

(3016879) Cocaine [Presence] in Urine

0.96

0.00

1.7

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1.01

0.00

1.8

2.4

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.00

0.0

3.2

—

29.9

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.0

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

0.0

1.6

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.00

0.0

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.0

2.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.0

2.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.3

—

(4133840)

0.00

0.0

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.0

1.0

—

(3045414) Leukocytes [Presence] in Urine

1.01

0.00

1.3

1.7

—

(44806071)

0.00

0.0

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

0.96

0.00

1.0

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

0.0

1.4

—

(40768793) Breast Pathology biopsy report

0.94

0.00

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

0.89

0.00

2.6

1.7

134.2

243.7

pmol/l

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_BONE_CARTILAGE_NOS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_BONE_CARTILAGE_NOS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_BONE_CARTILAGE_NOS – Benign neoplasm: Bone and articular cartilage, unspecified

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Bone and articular cartilage, unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints